Benzalkonium chloride foruse in treating conjunctivitis and/or covid-19
Grant
US12594251B2
Kind: B2
Apr 07, 2026
Assignee
Bausch + Lomb Ireland Limited
Inventors
Patrick McCormick, Kimberly Millard
Abstract
Methods for treating coronavirus disease 2019 (COVID-19), including at least one ocular manifestation of COVID-19, methods for treating conjunctivitis, and methods for reducing COVID-19 transmission comprising administering an effective amount of benzalkonium chloride are disclosed. Pharmaceutical compositions comprising benzalkonium chloride are also disclosed.
CPC Classifications
A61K 31/14
A61P 27/02
A61P 31/14
Filing Date
2021-10-14
Application No.
18248841
Claims
40